Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
180 participants
OBSERVATIONAL
2023-05-16
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It will be also investigated if this hormonal milieu is a predictive factor for cardiovascular disease in obese patients.
Eligible subjects are male patients (age 18-80 years) with severe obesity and no other known causes of hypercortisolism or hypogonadism.
Questionnaires for the evaluation of mood and symptoms will be collected upon enrollment, patient's anamnestic and clinical data relating to disease complications, BMI, previous blood tests, cortisol suppression with dexamethasone 1 mg will be collected, and blood sample will be sent to and analyzed at a centralized laboratory for the study of Steroid hormones, bone metabolism, lipoprotein function, genetics and receptor analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corticosteroid-induced Lipodystrophy and Adipokines
NCT00822042
Energy Metabolism and Nutrient Absorption in Lean and Obese Individuals
NCT00414063
Pattern of Gene Expression in Adipose Tissue From Patients With Cushing Syndrome
NCT01688349
Characterization of Serum Proteome in Young Obese Subjects (POSING)
NCT05761210
Effect of Body Composition on Thyroid Hormone Levels Among Overweight and Obese Subjects
NCT04327375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* use of corticosteroids at the time of enrollment
* the patient's poor understanding of spoken and written Italian
* patients suffering from primary pathologies of the testicle, known at enrollment
* patients suffering from hypothalamic-pituitary or adrenal pathologies already known at the time of enrollment
18 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Italy
OTHER_GOV
Istituto Auxologico Italiano
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Auxlogico Italiano, Hospital San Giuseppe, Piancavallo
Oggebbio, Verbania, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05C308
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.